Chemical Name: Retatrutide (LY3437943) Classification: Triple hormone receptor agonist Mechanism: GLP-1/GIP/Glucagon receptor agonist Research Applications: Metabolic pathway research Glucose regulation mechanism studies Energy expenditure analysis Lipid metabolism research Incretin hormone pathway investigation Hepatic fat reduction studies Multi-receptor agonism research Product Specifications: Form: Lyophilized powder Purity: High purity research grade Storage: Store at -20C, protect from light and moisture Reconstitution: Use bacteriostatic water (not included) Stability: 24 months when stored properly, 30 days once reconstituted Research Background: Retatrutide is an investigational triple hormone receptor agonist that simultaneously targets GLP-1, GIP, and glucagon receptors
If you have followed the policy news, you may have heard of the BALANCE Model originally meant to pair medication access with mandatory lifestyle programs
One of the biggest mistakes people make on GLP-1 medications is assuming that its healthy or adequate to simply limit your food overall
Current animal studies show potential fetal risks, which is why major health organizations recommend discontinuing GLP-1 therapy three months before attempting conception
December 2020 Institute of Medicine
Some of the latest CGMs include Freestyle Libre 2 Plus sensor and Dexcom G7 sensor